Table 1.
Demographic characteristics, medical history, and follow-up of 458 symptomatic adult outpatients with COVID-19.
| No. (%)∗ | |||
| Characteristics | Never hospitalized (n = 423) | Hospitalized during follow-up (n = 35) | P value† |
| Sex | .43 | ||
| Male | 188 (44.4) | 18 (51.4) | |
| Female | 235 (55.6) | 17 (48.6) | |
| Age, median (range), y | 41 (18-93) | 52 (19-76) | .16‡ |
| Race | .82 | ||
| White | 316 (74.7) | 28 (80.0) | |
| Asian | 18 (4.3) | 2 (5.7) | |
| Black or African American | 18 (4.3) | 1 (2.9) | |
| Native American/Alaskan | 4 (1.0) | 0 (0) | |
| Other | 21 (5.0) | 1 (2.9) | |
| Not specified | 36 (8.5) | 3 (8.6) | |
| Hispanic/Latino ethnicity | 41 (9.7) | 4 (11.4) | .96 |
| Body mass index (n = 278) | .42 | ||
| Underweight (<18.5) | 6 (1.4) | 0 (0) | |
| Normal weight (18.5-24.9) | 77 (18.2) | 8 (22.9) | |
| Overweight (25.0–29.9) | 80 (18.9) | 9 (25.7) | |
| Obese (>30.0) | 82 (19.4) | 15 (42.9) | |
| Missing | 178 (42.1) | 3 (8.6) | |
| Comorbid condition§ | |||
| None | 178 (42.1) | 5 (14.3) | .001 |
| Hypertension | 84 (19.9) | 16 (45.7) | <.001 |
| Diabetes | 30 (7.1) | 11 (31.4) | <.001 |
| Pre-diabetes | 18 (4.3) | 2 (5.7) | .69 |
| Hyperlipidemia | 66 (15.6) | 14 (40.0) | <.001 |
| Atherosclerotic cardiovascular disease | 18 (4.3) | 8 (22.9) | <.001 |
| COPD | 10 (2.4) | 5 (14.3) | <.001 |
| Asthma | 49 (11.6) | 6 (17.1) | .33 |
| Chronic kidney disease|| | 5 (1.2) | 4 (11.4) | <.001 |
| Immunocompromised state¶ | 2 (0.5) | 3 (8.6) | <.001 |
| No. ED visits during follow-up | <.001# | ||
| 0 | 264 (62.4) | 4 (11.4) | |
| 1 | 89 (21.0) | 21 (60.0) | |
| 2 | 13 (3.1) | 5 (14.3) | |
| 3 or more | 4 (0.9) | 5 (14.3) | |
| Total visits | 128 | 48 | |
| Death from COVID-19 | 0 (0) | 2 (5.7) | |